Clinical trial participants should be representative of the larger population of colorectal cancer patients who will use the treatment being tested. Overly restrictive exclusion criteria, as well as the demands of clinical trial participation, can stand in the way of this goal. Under the umbrella of the Clinical Trial Awareness program, GCCA is partnering with industry to improve clinical trial design, patient recruitment, and participant retention. GCCA provides feedback to clinical trial designers about potentially restrictive clinical trial exclusion criteria and trial characteristics that make it difficult for patients to participate.
GCCA is building a global community of advocates and advocacy organizations to share information about how to make the most impact in the sphere of colorectal cancer advocacy and patient-centered policy. Our annual Global Colorectal Cancer Congress is a virtual event that brings together
- patients, survivors, and caregivers
- healthcare providers
- policymakers, including government representatives and payors
- policy experts
Past congresses have addressed disease state information and breakthroughs in the treatment of colorectal cancer as well as best practices for advocates and patient advocacy organizations. The focus of the 2023 Global CRC Congress is Equitable Access for All: Achieving Health Equity in Colorectal Cancer Screening, Testing, Treatment, and Care. Health equity leaders and policy experts share real life examples of successful advocacy efforts and provide attendees with the tools to take action in their own communities.